Hims & Hers Health, Inc.'s Q1 results show 111% growth, yet shares fell 8%. Click for a look at the impact of drug access, ...

“CI faces industry-wide cost pressures from stop-loss plans and higher medical utilization including deferred pandemic care,” ...